These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8888355)

  • 1. Effects of corticotropin-releasing hormone on ACTH, cortisol and 13, 14-dihydro-15-keto prostaglandin E2 in patients with diabetes insipidus before and after captopril treatment.
    Zacharieva S; Andreeva M; Orbetzova M; Wippermann M; Mucha I; Andonova K; Sheitanova S
    Prostaglandins Leukot Essent Fatty Acids; 1996 Jun; 54(6):433-7. PubMed ID: 8888355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of a specific effect of corticotropin-releasing hormone (CRH) on plasma levels of 13,14-dihydro-15-keto-prostaglandin E2 in normal subjects.
    Zacharieva S; Muchá I; Wippermann M; Sheitanova S; Andonova K
    Prostaglandins Leukot Essent Fatty Acids; 1995 Jan; 52(1):55-7. PubMed ID: 7708821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of prostaglandin E2 (PGE2) on the corticotropin-releasing hormone (CRH)-induced ACTH release in healthy men.
    Zacharieva S; Borissova AM; Andonova K; Stoeva I; Matrozov P
    Horm Metab Res; 1992 Jul; 24(7):336-8. PubMed ID: 1325403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma corticotrophin releasing hormone, vasopressin, ACTH and cortisol responses to acute myocardial infarction.
    Donald RA; Crozier IG; Foy SG; Richards AM; Livesey JH; Ellis MJ; Mattioli L; Ikram H
    Clin Endocrinol (Oxf); 1994 Apr; 40(4):499-504. PubMed ID: 8187316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indomethacin and meclofenamate do not alter ACTH and cortisol responses to corticotropin-releasing hormone (CRH) in normal subjects.
    Zacharieva S; Wippermann M; Muchá I; Andonova K; Jankova G
    Clin Physiol Biochem; 1993; 10(1):28-32. PubMed ID: 8393395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of plasma osmolality on pituitary-adrenal responses to corticotropin-releasing hormone and atrial natriuretic peptide changes in central diabetes insipidus.
    Elias LL; Antunes-Rodrigues J; Elias PC; Moreira AC
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1243-7. PubMed ID: 9100602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced adrenocorticotrophic hormone and cortisol responses to corticotrophin-releasing hormone in central idiopathic diabetes insipidus.
    Mazza E; Goffi S; Barchi P; Arvat E; Bellone J; Limone P; Ghigo E; Camanni F
    Eur J Endocrinol; 1994 Feb; 130(2):121-4. PubMed ID: 8130884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypothalamus-pituitary-adrenal axis in central diabetes insipidus: ACTH and cortisol responsiveness to CRH administration.
    Pivonello R; Faggiano A; Filippella M; Di Somma C; De Martino MC; Gaccione M; Lombardi G; Colao A
    J Endocrinol Invest; 2002 Dec; 25(11):932-7. PubMed ID: 12553551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of administration of corticotropin-releasing hormone and glucocorticoid on arginine vasopressin response to osmotic stimulus in normal subjects and patients with hypocorticotropinism without overt diabetes insipidus.
    Yamada K; Tamura Y; Yoshida S
    J Clin Endocrinol Metab; 1989 Aug; 69(2):396-401. PubMed ID: 2546964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of repetitive administration of corticotropin-releasing hormone combined with lysine vasopressin on plasma adrenocorticotropin and cortisol levels in secondary adrenocortical insufficiency.
    Fukata J; Usui T; Tsukada T; Nakai Y; Koh T; Ishihara T; Tanaka I; Uchida K; Yoshimasa T; Nakano R
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1624-31. PubMed ID: 2172283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the effects of human and ovine corticotropin-releasing hormone on the pituitary-adrenal axis.
    Trainer PJ; Faria M; Newell-Price J; Browne P; Kopelman P; Coy DH; Besser GM; Grossman AB
    J Clin Endocrinol Metab; 1995 Feb; 80(2):412-7. PubMed ID: 7852498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Responses induced by arginine-vasopressin injection in the plasma concentrations of adrenocorticotropic hormone, cortisol, growth hormone and metabolites around weaning time in goats.
    Katoh K; Yoshida M; Kobayashi Y; Onodera M; Kogusa K; Obara Y
    J Endocrinol; 2005 Nov; 187(2):249-56. PubMed ID: 16293772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Responsivity of adrenocorticotropin to corticotropin-releasing hormone and lack of suppressibility by dexamethasone are related phenomena in Cushing's disease.
    Hermus AR; Pieters GF; Pesman GJ; Smals AG; Benraad TJ; Kloppenborg PW
    J Clin Endocrinol Metab; 1986 Apr; 62(4):634-9. PubMed ID: 3005353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of angiotensin-converting enzyme inhibition on ACTH response to corticotropin-releasing hormone (CRH) in normal men.
    Zacharieva S; Matrozov P; Stoeva I; Andonova K
    Horm Metab Res; 1991 May; 23(5):245-6. PubMed ID: 1651896
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasma corticotropin and cortisol responses to ovine corticotropin-releasing hormone (CRH), arginine vasopressin (AVP), CRH plus AVP, and CRH plus metyrapone in patients with Cushing's disease.
    Dickstein G; DeBold CR; Gaitan D; DeCherney GS; Jackson RV; Sheldon WR; Nicholson WE; Orth DN
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2934-41. PubMed ID: 8768855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The corticotropin-releasing hormone test in the diagnosis of ACTH-dependent Cushing's syndrome: a reappraisal.
    Pecori Giraldi F; Invitti C; Cavagnini F;
    Clin Endocrinol (Oxf); 2001 May; 54(5):601-7. PubMed ID: 11380490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of restricting uteroplacental blood flow on concentrations of corticotrophin-releasing hormone, adrenocorticotrophin, cortisol, and prostaglandin E2 in the sheep fetus during late pregnancy.
    Sug-Tang A; Bocking AD; Brooks AN; Hooper S; White SE; Jacobs RA; Fraher LJ; Challis JR
    Can J Physiol Pharmacol; 1992 Oct; 70(10):1396-402. PubMed ID: 1337015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adrenergic modulation of adrenocorticotropin responses to insulin-induced hypoglycemia and corticotropin-releasing hormone.
    Tomori N; Suda T; Nakagami Y; Tozawa F; Sumitomo T; Ushiyama T; Demura H; Shizume K
    J Clin Endocrinol Metab; 1989 Jan; 68(1):87-93. PubMed ID: 2535853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship of saline-induced changes in vasopressin secretion to basal and corticotropin-releasing hormone-stimulated adrenocorticotropin and cortisol secretion in man.
    Rittmaster RS; Cutler GB; Gold PW; Brandon DD; Tomai T; Loriaux DL; Chrousos GP
    J Clin Endocrinol Metab; 1987 Feb; 64(2):371-6. PubMed ID: 3025246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desmopressin normalizes the blunted adrenocorticotropin response to corticotropin-releasing hormone in melancholic depression: evidence of enhanced vasopressinergic responsivity.
    Dinan TG; Lavelle E; Scott LV; Newell-Price J; Medbak S; Grossman AB
    J Clin Endocrinol Metab; 1999 Jun; 84(6):2238-40. PubMed ID: 10372738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.